RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury (Q37353986)
Jump to navigation
Jump to search
scientific article published on 13 May 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury |
scientific article published on 13 May 2016 |
Statements
1 reference
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury (English)
1 reference
K Newton
D L Dugger
A Maltzman
J M Greve
M Hedehus
B Martin-McNulty
R A D Carano
T C Cao
N van Bruggen
L Bernstein
W P Lee
X Wu
J DeVoss
J Zhang
S Jeet
I Peng
B S McKenzie
M Roose-Girma
L Diehl
J D Webster